Asked by: Emma Hardy (Labour - Kingston upon Hull West and Hessle)
Question
To ask the Minister for Women and Equalities, If she will make an assessment of the potential impact on women's health of the Government's progress on implementing the recommendations of the report of the Independent Medicines and Medical Devices Safety Review entitled First Do No Harm, published on 8 July 2020.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Patient safety and women’s health is a top priority for this Government.
That’s why since the ‘First Do No Harm’ report we have:
o Appointed England’s first Patient Safety Commissioner
o Setup specialist centres for women impacted by mesh
o Piloted ways doctors can declare their interests
o And launched a national mandatory Medical Device Outcome Registry.
Beyond this, we published the first Women’s Health Strategy for England, which set out our plans for improving how the health and care system listens to women.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, further to the Independent Medicines and Medical Devices Safety Review report First Do No Harm, published on 8 July 2020, what discussions they have had regarding the provision of monetary compensation for people adversely affected by clinical and surgical pelvic mesh.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has asked the Patient Safety Commissioner, Dr Henrietta Hughes, to undertake work looking at redress for people harmed by pelvic mesh and sodium valproate. The work is intended to focus on the views of those affected, improving the understanding of how many people have been affected and how, the case for redress and what form it could take.
The Patient Safety Commissioner office has stated that the report setting out the findings from this work is expected to be published on 7 February this year. The Government will consider the report’s findings before deciding how to proceed on this matter.
The Government published its response to the Independent Medicines and Medical Devices Safety review in July 2021, which did not accept the recommendation to establish a redress agency, this position remains unchanged.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what recent assessment they have made of the recommendation for an Independent Redress Agency in the Independent Medicines and Medical Devices Safety Review report First Do No Harm, published on 8 July 2020.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has asked the Patient Safety Commissioner, Dr Henrietta Hughes, to undertake work looking at redress for people harmed by pelvic mesh and sodium valproate. The work is intended to focus on the views of those affected, improving the understanding of how many people have been affected and how, the case for redress and what form it could take.
The Patient Safety Commissioner office has stated that the report setting out the findings from this work is expected to be published on 7 February this year. The Government will consider the report’s findings before deciding how to proceed on this matter.
The Government published its response to the Independent Medicines and Medical Devices Safety review in July 2021, which did not accept the recommendation to establish a redress agency, this position remains unchanged.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government when they intend to implement all of the recommendations contained in the Independent Medicines and Medical Devices Safety Review report First Do No Harm, published on 8 July 2020.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Independent Medicines and Medical Devices Safety (IMMDS) Review was clear in its finding that the healthcare system failed to listen to patients’ concerns on the issues covered by the review. The Government’s 2021 response to the review set out which of the review’s recommendations the Government had accepted. We also published an update in an online-only format in December 2022 setting out progress made against those recommendations, which includes appointing the first ever Patient Safety Commissioner in England to champion patients’ voices in relation to the safety of medicines and medical devices. In April 2023, the Government also responded to the recommendations made by the Health and Social Care Committee in its report ‘Follow-up on the IMMDS report and the Government’s response’, published in January 2023. A copy of the follow-up report is attached.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the Independent Medicines and Medical Devices Safety Review report First Do No Harm, published on 8 July 2020.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Independent Medicines and Medical Devices Safety (IMMDS) Review was clear in its finding that the healthcare system failed to listen to patients’ concerns on the issues covered by the review. The Government’s 2021 response to the review set out which of the review’s recommendations the Government had accepted. We also published an update in an online-only format in December 2022 setting out progress made against those recommendations, which includes appointing the first ever Patient Safety Commissioner in England to champion patients’ voices in relation to the safety of medicines and medical devices. In April 2023, the Government also responded to the recommendations made by the Health and Social Care Committee in its report ‘Follow-up on the IMMDS report and the Government’s response’, published in January 2023. A copy of the follow-up report is attached.
Asked by: Baroness Merron (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the risk of being pressured into showing confidential medical records on the NHS App to third parties faced by (1) patients requesting covert contraception forbidden in their home or relationship, (2) patients who are suffering domestic abuse, and (3) other vulnerable groups including the elderly.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government wants people to be able to have access to their own records if they choose to do so. There is widespread international consensus about the benefits to patients and the effectiveness of the health system in providing digital on-demand access to personal health information.
For most, online record access is beneficial, but for a minority, having access could cause harm or distress. NHS England is taking an active approach to ensuring safe and secure patient record access, seeking to identify and provide additional protections to vulnerable people if they request access to their medical records online.
NHS England has engaged extensively with at-risk groups, professional bodies, patient groups, charities and safeguarding leads to support general practice and patients in preparing for this change safely and effectively. Communication packs have been provided to over 50 charities that support at-risk individuals. NHS Digital has published guidance in an online-only format for organisations, Supporting victims and survivors of domestic or sexual abuse, to support people when accessing their personal health information online.
Before viewing their record in the NHS App, users are advised what to do if they are being pressured to share their information. Patients can prevent access by disabling their National Health Service login with a simple online process or can ask their general practitioner (GP) for the details of specific consultations or treatment decisions to be redacted. When an individual first requests access, they cannot see information already recorded; they will only be able to access information recorded from that point onwards.
The expert safeguarding group has identified theoretical risks, which have fed into NHS England’s patient and GP communications packs and advice, messaging on the NHS App and NHS.uk and improvements made by GP IT system suppliers.
More than 23 million patients have viewed their records over nine million times, with no significant incidents relating to personal safety or security reported. Lower-level incidents, such as people finding out their diagnosis before being told by a clinician, have been reported, and some issues have been investigated and classed as low-risk and/or resolved.
NHS England continues to monitor this and would take action if an issue was identified or raised.
Asked by: Baroness Merron (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what consideration has been given to making it simpler to switch off access to patient health records through the NHS app, particularly for vulnerable groups.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government wants people to be able to have access to their own records if they choose to do so. There is widespread international consensus about the benefits to patients and the effectiveness of the health system in providing digital on-demand access to personal health information.
For most, online record access is beneficial, but for a minority, having access could cause harm or distress. NHS England is taking an active approach to ensuring safe and secure patient record access, seeking to identify and provide additional protections to vulnerable people if they request access to their medical records online.
NHS England has engaged extensively with at-risk groups, professional bodies, patient groups, charities and safeguarding leads to support general practice and patients in preparing for this change safely and effectively. Communication packs have been provided to over 50 charities that support at-risk individuals. NHS Digital has published guidance in an online-only format for organisations, Supporting victims and survivors of domestic or sexual abuse, to support people when accessing their personal health information online.
Before viewing their record in the NHS App, users are advised what to do if they are being pressured to share their information. Patients can prevent access by disabling their National Health Service login with a simple online process or can ask their general practitioner (GP) for the details of specific consultations or treatment decisions to be redacted. When an individual first requests access, they cannot see information already recorded; they will only be able to access information recorded from that point onwards.
The expert safeguarding group has identified theoretical risks, which have fed into NHS England’s patient and GP communications packs and advice, messaging on the NHS App and NHS.uk and improvements made by GP IT system suppliers.
More than 23 million patients have viewed their records over nine million times, with no significant incidents relating to personal safety or security reported. Lower-level incidents, such as people finding out their diagnosis before being told by a clinician, have been reported, and some issues have been investigated and classed as low-risk and/or resolved.
NHS England continues to monitor this and would take action if an issue was identified or raised.
Asked by: Baroness Merron (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what advice is being provided to domestic abuse survivors and other at-risk groups about medical apps they have downloaded on their devices.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government wants people to be able to have access to their own records if they choose to do so. There is widespread international consensus about the benefits to patients and the effectiveness of the health system in providing digital on-demand access to personal health information.
For most, online record access is beneficial, but for a minority, having access could cause harm or distress. NHS England is taking an active approach to ensuring safe and secure patient record access, seeking to identify and provide additional protections to vulnerable people if they request access to their medical records online.
NHS England has engaged extensively with at-risk groups, professional bodies, patient groups, charities and safeguarding leads to support general practice and patients in preparing for this change safely and effectively. Communication packs have been provided to over 50 charities that support at-risk individuals. NHS Digital has published guidance in an online-only format for organisations, Supporting victims and survivors of domestic or sexual abuse, to support people when accessing their personal health information online.
Before viewing their record in the NHS App, users are advised what to do if they are being pressured to share their information. Patients can prevent access by disabling their National Health Service login with a simple online process or can ask their general practitioner (GP) for the details of specific consultations or treatment decisions to be redacted. When an individual first requests access, they cannot see information already recorded; they will only be able to access information recorded from that point onwards.
The expert safeguarding group has identified theoretical risks, which have fed into NHS England’s patient and GP communications packs and advice, messaging on the NHS App and NHS.uk and improvements made by GP IT system suppliers.
More than 23 million patients have viewed their records over nine million times, with no significant incidents relating to personal safety or security reported. Lower-level incidents, such as people finding out their diagnosis before being told by a clinician, have been reported, and some issues have been investigated and classed as low-risk and/or resolved.
NHS England continues to monitor this and would take action if an issue was identified or raised.
Asked by: Baroness Merron (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether any concerns about risk to personal safety and security have been identified by the expert safeguarding group reviewing the implementation of NHS App.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government wants people to be able to have access to their own records if they choose to do so. There is widespread international consensus about the benefits to patients and the effectiveness of the health system in providing digital on-demand access to personal health information.
For most, online record access is beneficial, but for a minority, having access could cause harm or distress. NHS England is taking an active approach to ensuring safe and secure patient record access, seeking to identify and provide additional protections to vulnerable people if they request access to their medical records online.
NHS England has engaged extensively with at-risk groups, professional bodies, patient groups, charities and safeguarding leads to support general practice and patients in preparing for this change safely and effectively. Communication packs have been provided to over 50 charities that support at-risk individuals. NHS Digital has published guidance in an online-only format for organisations, Supporting victims and survivors of domestic or sexual abuse, to support people when accessing their personal health information online.
Before viewing their record in the NHS App, users are advised what to do if they are being pressured to share their information. Patients can prevent access by disabling their National Health Service login with a simple online process or can ask their general practitioner (GP) for the details of specific consultations or treatment decisions to be redacted. When an individual first requests access, they cannot see information already recorded; they will only be able to access information recorded from that point onwards.
The expert safeguarding group has identified theoretical risks, which have fed into NHS England’s patient and GP communications packs and advice, messaging on the NHS App and NHS.uk and improvements made by GP IT system suppliers.
More than 23 million patients have viewed their records over nine million times, with no significant incidents relating to personal safety or security reported. Lower-level incidents, such as people finding out their diagnosis before being told by a clinician, have been reported, and some issues have been investigated and classed as low-risk and/or resolved.
NHS England continues to monitor this and would take action if an issue was identified or raised.
Asked by: Baroness Bennett of Manor Castle (Green Party - Life peer)
Question to the Department for Environment, Food and Rural Affairs:
To ask His Majesty's Government what assessment they have made of the report in the Lancet First, do no harm: time for a systems approach to address the problem of health-care-derived pharmaceutical pollution, published in December 2022; and what steps, if any, they plan to take regarding its recommendations.
Answered by Lord Benyon - Minister of State (Foreign, Commonwealth and Development Office)
Defra and its agencies, including the Environment Agency, have not yet considered the report in full detail but will do so in due course. We will consider the recommendations in conjunction with officials in the Department for Health and Social Care. Defra has already noted that some of the suggested interventions in the Lancet paper may be relevant to veterinary medicines. The Veterinary Medicines Directorate within Defra is actively considering issues around pharmaceuticals in the environment, and conducts environmental risk assessments for all new veterinary medicines.